Evidence map›Paper›PMID 37805966›Full record

ArticleArchives of virology2023

Analysis of miRNA expression profiles in exosomes of SMB-S15 cells treated with resveratrol.

Qiang Shi, Lina Zhang, Xiemusiye Wulayin, Rundong Cao, Mingyuan Jiao, Jing Wang, Jun Han, Xiao-Ping Dong, Chen Gao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Qiang ShiTongzhou Maternal and Child Health Hospital of Beijing, Beijing, 101100, China.
Lina ZhangState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China.
Xiemusiye WulayinState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China.
Rundong CaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China.
Mingyuan JiaoTongzhou Maternal and Child Health Hospital of Beijing, Beijing, 101100, China.
Jing WangState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China.
Jun HanState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China.
Xiao-Ping DongState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China. dongxiaoping@ivdc.chinacdc.cn.
Chen GaoState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases (Zhejiang University), Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Chang-Bai Rd 155, Beijing, 102206, People's Republic of China. gaochen@ivdc.chinacdc.cn.ORCID http://orcid.org/0000-0003-1390-5581
National Institute for Viral Disease Control and Prevention · CNChongqing Maternal and Child Health Hospital · CNChinese Center For Disease Control and Prevention · CN

Funding

Chinese National Natural Science Foundation Grants 81601810Chinese National Natural Science Foundation Grants 81630062Research Project 2016YFC1202402Research Project 2016YFC1202700Research Project 2017YFC1200500Research Project 2018ZX10734404-003State Key Laboratory of Infectious Disease Prevention and Control 2015SKLID503State Key Laboratory of Infectious Disease Prevention and Control 2016SKLID603
6 · The paper itself

Abstract

Exosomes are double-layered vesicle bodies secreted by cells, in which microRNAs (miRNAs) play an important role. In a previous study, we found that treatment of the prion-infected cell line SMB-S15 with resveratrol can effectively inhibit the propagation of PrP

Indexed as

ExosomesMicroRNAsPrion DiseasesPrionsHumansResveratrolMicroRNAsPrionsResveratrol

Identifiers

PMID37805966
PMCPMC10560638
OpenAlexW4387439662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.